These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparison between anticoagulant activity and antigenicity of plasma antithrombin III in healthy subjects and patients with disseminated intravascular coagulation (DIC) (author's transl)]. Matsuda T, Ogawara M, Miura R, Seki T, Yokouchi M, Murakami M, Fujisawa M, Nakanishi K, Nakamura S. Rinsho Ketsueki; 1980 Mar; 21(3):341-6. PubMed ID: 6157843 [No Abstract] [Full Text] [Related]
3. Antithrombin III during liver transplantation. Lewis JH, Bontempo FA, Ragni MV, Starzl TE. Transplant Proc; 1989 Jun; 21(3):3543-4. PubMed ID: 2662520 [No Abstract] [Full Text] [Related]
4. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Ben-Ari Z, Osman E, Hutton RA, Burroughs AK. Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855 [Abstract] [Full Text] [Related]
8. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia]. Hashizume K, Tanaki T, Horita H, Yoshitani H, Kumatani Y, Matsuda T, Ito K. Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561 [No Abstract] [Full Text] [Related]
10. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease. Mombelli G, Fiori G, Monotti R, Haeberli A, Straub PW. J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084 [Abstract] [Full Text] [Related]
11. [Consumption of antithrombin III in plasma (author's transl)]. Matsuda T. Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):597-603. PubMed ID: 696198 [No Abstract] [Full Text] [Related]
14. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency]. Carmignoto F, Schivo P, Plebani M, Pengo V, Piccini P, Ceriotti G. Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980 [Abstract] [Full Text] [Related]
17. Measurements of antithrombin III in solid tumor patients with and without hepatic metastases. Rubin RN, Kies MS, Posch JJ. Thromb Res; 1981 Jun; 18(3-4):353-60. PubMed ID: 7414535 [No Abstract] [Full Text] [Related]
18. [Antithrombin III: the correlation structure-function in healthy people and in cirrhotic patients (author's transl)]. Vicente JM, Díaz Cremades JM, Borrell M, Felez J, Gimferrer E, Pujol N, Domingo A, Rutllant ML. Sangre (Barc); 1978 Jun; 23(5):544-53. PubMed ID: 368998 [No Abstract] [Full Text] [Related]
19. [The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors]. Zurborn KH, Gram J, Rohwedder E, Bewig B, Bruhn HD. Med Klin (Munich); 1989 Nov 15; 84(11):515-8. PubMed ID: 2593977 [Abstract] [Full Text] [Related]
20. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories. Cucuianu M, Cristea A, Vonica A, Lascu I. Med Interne; 1988 Nov 15; 26(3):191-7. PubMed ID: 3187359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]